Meaningful collaboration between patients, sites, and sponsors can yield improved clinical trial outcomes. As part of that important collaboration, we see that effective patient input has the potential to increase patient participation rates in clinical trials. Incorporating patient insights into clinical trial design and execution is the first step.
Patient voice isn’t an accessory; it’s foundational. Including the patient voice in study design and development can make an enormous difference in recruitment, enrollment, and retention. Doing so also pleases regulators, who are increasingly putting a premium on patient-focused drug development. It doesn’t have to be difficult, but getting it wrong — or not doing it at all — can undermine a trial.
This podcast features an interview with Dr. David Fajgenbaum, assistant professor of medicine at the University of Pennsylvania and author of Chasing My Cure: A Doctor’s Race to Turn Hope Into Action. Hear Dr. Fajgenbaum discuss what it’s like to be a patient of a rare disease — in this case Castleman’s disease — and the incredible story of his fight to find a cure.
Patients and their advocates can — and do! — use their collective voice to promote transformation through the legislative process. It can be a protracted process, but it can yield dramatic changes in policy that speed drug development and enhance safety.